Piers Ingram is the Chief Executive Officer and co-founder of Hummingbird Bioscience. Excited by the increasing pace of progress in systems biology and immunology, Piers co-founded the company in 2015 to better apply these advances to drug discovery and development. Prior to co-founding Hummingbird Bioscience, Piers spent 15 years in the biopharmaceutical industry in R&D consulting, commercial strategy and academia. Between 2013 and 2015, Piers was employed by Sanofi (NASDAQ: SNY) as Head of Strategic Planning, South East Asia, and between 2011 and 2013 at Monitor Group (and then Monitor Deloitte) as a Manager in the Strategy Consulting practice. Between 2008 and 2010, Piers was first a Research Fellow and then acting Research Group Head at the Centre for Integrative Systems Biology, Imperial College London. Piers holds an MSci in Mathematics, an MSc in Bioinformatics and a PhD in Systems Biology from Imperial College London, and an MBA from INSEAD.